RECRUITINGOBSERVATIONAL
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
About This Trial
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Who May Be Eligible (Plain English)
Who May Qualify:
- Interstitial lung disease
Who Should NOT Join This Trial:
- Does not have Interstitial lung disease
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Interstitial lung disease
Exclusion Criteria:
* Does not have Interstitial lung disease
Locations (1)
University of Chicago
Chicago, Illinois, United States